There is a subset of patients who present initially with an unexpectedly low AMH level. These situations precipitate concern about short-and long-term female reproductive function. A later discordant confirmatory test raises questions about whether the lower or the higher level is the better predictor of ovarian reserve and responsiveness. This study sought to evaluate whether oocyte yields in patients with discordant AMH levels were more similar to those of patients with concordantly normal or abnormal levels.
Patients with two abnormal AMH measurements (n=36 completed cycles) obtained significantly fewer oocytes (6.6 ±3.5) than those with two normal AMH measurements (n=51) (11.5 ±5.8) (p<0.001) after controlling for oocyte age. Patients whose first AMH was normal and second AMH was abnormal (n=10) obtained fewer oocytes (9.5 ±6.6) than those with two normal AMH measurements (p<0.05) but more than patients with two abnormal AMH measurements (p<0.005) after controlling for oocyte age. Patients whose first AMH was abnormal and second AMH was normal (n=17) obtained no fewer oocytes (11.4 ±7.1) than those with two normal AMH measurements (p=0.77) after controlling for oocyte age. 
Conclusions:
Ovarian reserve in patients with an abnormal AMH level that normalizes upon repeat testing ultimately has normal ovarian reserve. It is possible that some initially low AMH levels might have been caused by long term OCP or hypothalamic suppression of the pituitary-ovarian axis with associated suppression of ovarian AMH production. Patients whose repeat AMH testing normalizes should be counseled that their more recent normal value may mitigate their previous abnormal one. A patient with a normal then abnormal AMH can anticipate outcomes in between those of consistently normal and consistently abnormal AMH patients. The Effect of Repeat AMH Measurements On VOR
Support: None

